|
DE102004031656A1
(de)
*
|
2004-06-30 |
2006-01-19 |
Merck Patent Gmbh |
Tetrahydrochinoline
|
|
SI2268618T1
(sl)
|
2008-03-03 |
2015-09-30 |
Novartis Ag |
Spojine in sestavki kot modulatorji aktivnosti TLR
|
|
TWI547522B
(zh)
|
2009-07-07 |
2016-09-01 |
愛爾康研究有限公司 |
環氧乙烷環氧丁烷嵌段共聚物組成物
|
|
IN2012DN02596A
(enExample)
*
|
2009-08-26 |
2015-08-28 |
Cylene Pharmaceuticals Inc |
|
|
JP2013053070A
(ja)
*
|
2009-11-06 |
2013-03-21 |
Takeda Chem Ind Ltd |
ジヒドロピロロキノリン誘導体
|
|
TW201200518A
(en)
*
|
2010-03-10 |
2012-01-01 |
Kalypsys Inc |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
DE102010025786A1
(de)
*
|
2010-07-01 |
2012-01-05 |
Merck Patent Gmbh |
Pyrazolochinoline
|
|
TW201206936A
(en)
|
2010-07-19 |
2012-02-16 |
Alcon Res Ltd |
Methods and compositions for the treatment of allergy
|
|
US9540379B2
(en)
|
2011-01-31 |
2017-01-10 |
Boehringer Ingelheim International Gmbh |
(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
|
|
MX365784B
(es)
*
|
2011-04-21 |
2019-05-28 |
Origenis Gmbh |
Compuestos heterociclicos como inhibidores de cinasas.
|
|
US8859550B2
(en)
|
2011-09-12 |
2014-10-14 |
Kalypsys, Inc. |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
FI3461825T3
(fi)
*
|
2011-09-30 |
2023-08-17 |
C&C Res Lab |
Uusia heterosyklisiä johdannaisia ja niiden käyttöjä
|
|
EP2763677B1
(en)
*
|
2011-10-04 |
2020-02-26 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
|
US20140045856A1
(en)
|
2012-07-31 |
2014-02-13 |
Boehringer Ingelheim International Gmbh |
4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
|
|
US10000482B2
(en)
|
2012-10-19 |
2018-06-19 |
Origenis Gmbh |
Kinase inhibitors
|
|
WO2014087208A2
(en)
*
|
2012-12-06 |
2014-06-12 |
Enaltec Labs Pvt. Ltd. |
A process of preparing alcaftadine
|
|
EP2950649B1
(en)
|
2013-02-01 |
2020-03-04 |
Wellstat Therapeutics Corporation |
Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity
|
|
US20160039842A1
(en)
*
|
2013-03-15 |
2016-02-11 |
Epigenetix, Inc. |
Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
|
|
WO2015012704A1
(en)
*
|
2013-07-25 |
2015-01-29 |
Uniwersytet Jagielloński |
Pyrroloquinoline derivatives as 5-ht6 antagonists, preparation method and use thereof
|
|
EP3307067B1
(en)
*
|
2015-06-11 |
2022-11-02 |
Merck Sharp & Dohme LLC |
Aminopyrazine compounds with a2a antagonist properties
|
|
US11028090B2
(en)
|
2017-01-26 |
2021-06-08 |
Dong Wha Pharm. Co., Ltd. |
[1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient
|
|
WO2019177971A1
(en)
*
|
2018-03-12 |
2019-09-19 |
Mavupharma, Inc. |
Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof
|
|
WO2019200500A1
(zh)
|
2018-04-15 |
2019-10-24 |
苏州大学张家港工业技术研究院 |
1,2,4-三氮唑及其制备方法
|
|
WO2019206242A1
(zh)
*
|
2018-04-27 |
2019-10-31 |
北京鼎材科技有限公司 |
有机电致发光材料及器件
|
|
TW202021969A
(zh)
*
|
2018-05-31 |
2020-06-16 |
南韓商Ｃ＆Ｃ新藥研究所 |
雜環衍生物及其用途
|
|
CN109705141B
(zh)
*
|
2019-02-20 |
2020-05-29 |
苏州大学 |
一种恶唑并喹啉类化合物及其制备方法与应用
|
|
WO2021098734A1
(zh)
*
|
2019-11-19 |
2021-05-27 |
南京明德新药研发有限公司 |
作为atm抑制剂的有取代的喹啉吡咯酮类合物及其应用
|
|
US11530218B2
(en)
|
2020-01-20 |
2022-12-20 |
Incyte Corporation |
Spiro compounds as inhibitors of KRAS
|
|
US11739102B2
(en)
|
2020-05-13 |
2023-08-29 |
Incyte Corporation |
Fused pyrimidine compounds as KRAS inhibitors
|
|
US11999752B2
(en)
|
2020-08-28 |
2024-06-04 |
Incyte Corporation |
Vinyl imidazole compounds as inhibitors of KRAS
|
|
US11767320B2
(en)
|
2020-10-02 |
2023-09-26 |
Incyte Corporation |
Bicyclic dione compounds as inhibitors of KRAS
|
|
WO2022204112A1
(en)
|
2021-03-22 |
2022-09-29 |
Incyte Corporation |
Imidazole and triazole kras inhibitors
|
|
EP4067357A1
(en)
*
|
2021-03-30 |
2022-10-05 |
JW Pharmaceutical Corporation |
Novel crystalline form of 1-(8-bromopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl)-n-methylazetidin-3-amine hydrogen sulfate monohydrate
|
|
US12441727B2
(en)
|
2021-07-07 |
2025-10-14 |
Incyte Corporation |
Tricyclic compounds as inhibitors of KRAS
|
|
CA3229855A1
(en)
|
2021-08-31 |
2023-03-09 |
Incyte Corporation |
Naphthyridine compounds as inhibitors of kras
|
|
WO2023049697A1
(en)
|
2021-09-21 |
2023-03-30 |
Incyte Corporation |
Hetero-tricyclic compounds as inhibitors of kras
|
|
WO2023056421A1
(en)
|
2021-10-01 |
2023-04-06 |
Incyte Corporation |
Pyrazoloquinoline kras inhibitors
|
|
KR20240101561A
(ko)
|
2021-10-14 |
2024-07-02 |
인사이트 코포레이션 |
Kras의 저해제로서의 퀴놀린 화합물
|
|
CN116969943A
(zh)
*
|
2022-04-28 |
2023-10-31 |
轩竹生物科技股份有限公司 |
三并环类二酰甘油激酶抑制剂及其用途
|
|
CN119053603A
(zh)
*
|
2022-08-03 |
2024-11-29 |
上海和誉生物医药科技有限公司 |
一种含氮三稠环prmt5抑制剂，其制备方法和药学上的用途
|
|
EP4592289A1
(en)
*
|
2022-09-26 |
2025-07-30 |
Shanghai Apeiron Therapeutics Company Limited |
Novel prmt5 inhibitor and use thereof
|
|
WO2024069235A2
(en)
|
2022-09-30 |
2024-04-04 |
Sixfold Bioscience Ltd. |
Compositions containing oligonucleotides with theranostic applications
|
|
CN116332789A
(zh)
*
|
2023-03-10 |
2023-06-27 |
上海康鹏科技股份有限公司 |
一种4-氨基-2-氟苯甲酰胺的制备方法
|